Guardian Pharmacy Services Inc. | Small-cap | Healthcare
$26.29
0.92%
| Guardian Pharmacy Stock Comparison:
Guardian Pharmacy vs HCA HealthcareGuardian Pharmacy vs Tenet HealthcareGuardian Pharmacy vs Acadia HealthcareGuardian Pharmacy vs Select MedicalGuardian Pharmacy vs PacsGuardian Pharmacy vs S&P 500 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 329.3M
Gross Profit 64.3M 19.54%
Operating Income 13.0M 3.95%
Net Income 9.3M 2.82%
EPS (Diluted) $0.15

Balance Sheet Metrics

Total Assets 334.0M
Total Liabilities 170.8M
Shareholders Equity 163.2M
Debt to Equity 1.05

Cash Flow Metrics

Operating Cash Flow 20.6M
Free Cash Flow 11.7M

Revenue & Profitability Trend

Guardian Pharmacy Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i1.2B1.0B908.9M792.1M736.0M
Cost of Goods Sold i984.0M837.9M723.0M630.8M589.0M
Gross Profit i244.4M208.3M185.9M161.3M147.0M
Gross Margin % i19.9%19.9%20.4%20.4%20.0%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i307.3M167.4M133.9M131.1M102.5M
Other Operating Expenses i---3.4M--
Total Operating Expenses i307.3M167.4M130.5M131.1M102.5M
Operating Income i-62.9M40.9M52.0M30.2M32.9M
Operating Margin % i-5.1%3.9%5.7%3.8%4.5%
Non-Operating Items
Interest Income i-----
Interest Expense i3.3M2.9M1.9M1.6M2.2M
Other Non-Operating Income-279.0K-367.0K-403.0K-187.0K-1.1M
Pre-tax Income i-66.5M37.7M49.7M28.3M29.7M
Income Tax i4.6M0---
Effective Tax Rate % i0.0%0.0%0.0%0.0%0.0%
Net Income i-71.0M37.7M49.7M28.3M29.7M
Net Margin % i-5.8%3.6%5.5%3.6%4.0%
Key Metrics
EBITDA i-43.4M58.8M68.2M46.5M50.0M
EPS (Basic) i$-1.77$0.00$0.58$0.27$0.33
EPS (Diluted) i$-1.77$0.00$0.58$0.27$0.33
Basic Shares Outstanding i6200581160844123608441236084412360844123
Diluted Shares Outstanding i6200581160844123608441236084412360844123

Income Statement Trend

Guardian Pharmacy Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i4.7M752.0K607.0K15.0M6.4M
Short-term Investments i-----
Accounts Receivable i97.2M77.3M67.8M55.2M45.8M
Inventory i40.6M36.7M41.4M33.1M31.9M
Other Current Assets9.6M14.9M10.1M8.5M6.8M
Total Current Assets i152.0M129.6M120.0M111.9M93.8M
Non-Current Assets
Property, Plant & Equipment i97.7M88.6M79.3M67.2M63.8M
Goodwill i153.5M124.1M126.5M126.4M124.0M
Intangible Assets i14.9M12.0M14.4M17.1M19.1M
Long-term Investments-----
Other Non-Current Assets5.7M358.0K435.0K529.0K505.0K
Total Non-Current Assets i168.8M141.6M136.1M124.0M124.0M
Total Assets i320.8M271.2M256.1M235.8M217.9M
Liabilities
Current Liabilities
Accounts Payable i102.4M85.6M78.1M64.6M53.4M
Short-term Debt i6.8M19.2M13.5M9.6M12.6M
Current Portion of Long-term Debt-----
Other Current Liabilities20.4M16.2M6.5M8.7M-
Total Current Liabilities i144.1M138.0M112.0M111.5M86.4M
Non-Current Liabilities
Long-term Debt i23.3M41.8M43.3M40.8M46.3M
Deferred Tax Liabilities i-----
Other Non-Current Liabilities3.4M31.5M24.9M3.0M3.3M
Total Non-Current Liabilities i26.7M73.3M68.2M71.0M64.4M
Total Liabilities i170.8M211.3M180.2M182.5M150.8M
Equity
Common Stock i63.0K----
Retained Earnings i17.1M----
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i150.0M59.9M75.9M53.3M67.1M
Key Metrics
Total Debt i30.1M61.0M56.8M50.4M58.8M
Working Capital i7.9M-8.4M8.0M331.0K7.5M

Balance Sheet Composition

Guardian Pharmacy Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i-71.0M37.7M49.7M28.3M29.7M
Depreciation & Amortization i19.8M18.2M16.6M16.5M17.3M
Stock-Based Compensation i131.5M-6.1M-3.4M13.0M3.2M
Working Capital Changes i-26.4M12.6M-18.7M-1.5M-1.1M
Operating Cash Flow i54.6M62.7M44.4M56.3M50.0M
Investing Activities
Capital Expenditures i-16.4M-14.6M-16.8M-9.3M-8.3M
Acquisitions i-14.7M-985.0K-2.0M-4.4M-4.4M
Investment Purchases i-----
Investment Sales i-----
Investing Cash Flow i-30.4M-13.4M-17.9M-13.1M-12.2M
Financing Activities
Share Repurchases i-55.2M0---
Dividends Paid i-35.8M-38.4M-30.8M-17.4M-10.8M
Debt Issuance i15.0M0--0
Debt Repayment i-240.8M-272.4M-255.8M-17.1M-100.4M
Financing Cash Flow i-221.9M-321.7M-294.0M-47.8M-128.3M
Free Cash Flow i41.6M56.3M31.8M49.2M44.3M
Net Change in Cash i-197.8M-272.4M-267.5M-4.6M-90.5M

Cash Flow Trend

Guardian Pharmacy Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 90.13
Forward P/E 28.59
Price to Book 9.28
Price to Sales 1.19
PEG Ratio -6.39

Profitability Ratios

Profit Margin -5.19%
Operating Margin 4.38%
Return on Equity -52.74%
Return on Assets -10.92%

Financial Health

Current Ratio 1.18
Debt to Equity 22.18

Per Share Data

EPS (TTM) $-1.48
Book Value per Share $2.68
Revenue per Share $21.24

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
grdn1.6B90.139.28-52.74%-5.19%22.18
HCA Healthcare 94.2B16.91-76.8113,631.68%8.21%-37.45
Tenet Healthcare 15.7B11.184.2029.65%7.18%158.70
Acadia Healthcare 1.9B13.800.624.83%4.31%74.74
Select Medical 1.8B23.211.077.72%3.33%136.22
Pacs 1.8B19.413.15110.96%2.59%469.36

Financial data is updated regularly. All figures are in the company's reporting currency.